Sr no. |
Generic Name |
Composition |
Pharma Ref. |
Strength |
Refrence |
1 |
Ketorolac Tromethamine Tablets IP |
Each uncoated dispersible tablet contains: |
|
|
(Sugam List dated: 21/04/1992) |
|
|
Ketorolac Tromethamine |
IP |
10mg |
|
2 |
Ivermectin Tablets IP 12mg |
Each uncoated dispersible tablet contains: |
|
|
Approved in Haryana |
|
|
Ivermectin |
IP |
12mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used |
|
|
|
3 |
Ivermectin Tablets IP 6mg |
Each uncoated dispersible tablet contains: |
|
|
Sugam list dated: 2004-June |
|
|
Ivermectin |
IP |
6mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used |
|
|
|
4 |
Esomeprazole Tablets IP 40mg |
Each enteric coated tablet contains |
|
|
(IP 2010 Page No. 1294) |
|
|
Esomerazole Magnesium Trihydrate |
IP |
|
|
|
|
Eq. to Esomeprazole |
|
40mg |
|
|
|
Colour: Approved colour used |
|
|
|
5 |
Esomeprazole Tablets IP 20mg |
Each enteric coated tablet contains |
|
|
(IP 2010 Page No. 1294) |
|
|
Esomerazole Magnesium Trihydrate |
IP |
|
|
|
|
Eq. to Esomeprazole |
|
20mg |
|
|
|
Colour: Approved colour used |
|
|
|
6 |
Fexofenadine Hydrochloride Tablets IP |
Each film coated tablet contains: |
|
|
(IP 2010 Page No. 1349 |
|
|
Fexofenadine Hydrochloride |
IP |
120mg |
|
|
|
Excipients q.s. |
|
|
|
|
|
Colour : Approved colour used |
|
|
|
7 |
Fexofenadine Hydrochloride Tablets IP |
Each film coated tablet contains: |
|
|
Sugam list dated: 16/09/1998 |
|
|
Fexofenadine Hydrochloride |
IP |
180mg |
|
|
|
Excipients q.s. |
|
|
|
|
|
Colour : Approved colour used |
|
|
|
8 |
Febuxostat Tablets 80mg |
Each film coated talbet contains |
|
|
(Sugam list dated: 16.01.10) |
|
|
Febuxostat |
|
80mg |
|
|
|
Excipients |
|
q.s. |
|
|
|
Colour : Approved colour used |
|
|
|
9 |
Febuxostat Tablets 40mg |
Each film coated talbet contains |
|
|
(Sugam list dated: 16.01.10) |
|
|
Febuxostat |
|
40mg |
|
|
|
Excipients |
|
q.s |
|
|
|
Colour : Approved colour used |
|
|
|
10 |
Rifaximin Tablets |
Each film coated tablet contains |
|
|
(Sugam list dated: 18.08.11) |
|
|
Rifaximin |
BP |
550mg |
|
|
|
Excipients |
|
q.s |
|
|
|
Colour : Approved colour used |
|
|
|
11 |
Methylprednisolone Tablets IP 4mg |
Each film coated tablet contains |
|
|
(IP 2010 Page No. 1674) |
|
|
Methylprednisolone |
IP |
4mg |
|
|
|
Colour : Approved colour used |
|
|
|
12 |
Methylprednisolone Tablets IP 8mg |
Each film coated tablet contains |
|
|
(IP 2010 Page No. 1674) |
|
|
Methylprednisolone |
IP |
8mg |
|
|
|
Colour : Approved colour used |
|
|
|
13 |
Methylprednisolone Tablets IP 16mg |
Each film coated tablet contains |
|
|
(IP 2010 Page No. 1674) |
|
|
Methylprednisolone |
IP |
16mg |
|
|
|
Colour : Approved colour used |
|
|
|
14 |
Etoricoxib Tablets IP 90 mg |
Each film coated tablet contains |
|
|
(Sugam List Dated: 2004-March) |
|
|
Etoricoxib |
IP |
90mg |
|
|
|
Colour : Approved colour used |
|
|
|
15 |
Etoricoxib Tablets IP 120 mg |
Each film coated tablet contains |
|
|
(Sugam List Dated: 2004-March) |
|
|
Etoricoxib |
IP |
120mg |
|
|
|
Each film coated tablet contains |
|
|
|
16 |
Drotavarine Hydrochloride Tablets IP |
Each film coated tablet contains: |
|
|
|
|
|
Drotavarine Hydrochloride |
IP |
80 mg |
|
|
|
Excipients |
|
q.s |
|
|
|
Colour: Approved colour used |
|
|
|
17 |
Levocetirizine Dhydrochloride Tablets IP 5mg |
Each film coated tablet contains |
|
|
(IP 2010 Page No. 1574) |
|
|
Levocetirizine Dhydrochloride |
IP |
5mg |
|
|
|
Colour: Approved colour used |
|
|
|
18 |
Fluconazole Tablets IP 150mg |
Each film coated tablet contains |
|
|
(IP 2010 Page No. 1354) |
|
|
Each uncoated tablet contains |
|
|
|
|
|
Fluconazole |
IP |
150mg |
|
19 |
Fluconazole Tablets IP 200mg |
Each uncoated tablet contains |
|
|
(IP 2010 Page No. 1354) |
|
|
Fluconazole |
IP |
200mg |
|
20 |
Cetirizine Hydrochloride Tablets 10 mg IP |
Each uncoated tablet contains |
|
|
(IP 2010 Page No. 1039) |
|
|
Cetrizine Hydrochloride |
IP |
10mg |
|
|
|
Excipients |
|
q.s |
|
21 |
Terbinafine Tablets IP 250mg |
Each uncoated tablet contains |
|
|
(Sugam list dated: 29/03/1995) |
|
|
Terbinafine Hydrochloride |
IP |
|
|
|
|
Eq, to Terbinafine |
|
250mg |
|
|
|
Excipients |
|
q.s |
|
22 |
Etizolam Tablets IP 0.25mg |
Each uncoated tablet contains |
|
|
(Sugam list dated: 03.07.10) |
|
|
Etizolam |
|
0.25mg |
|
|
|
Excipients |
|
q.s |
|
23 |
Ursodeoxycholic Acid Tablets IP 150mg |
Each film coated tablet contains |
|
|
(IP 2010 Page No. 12.04.2001) |
|
|
Ursoodeoxycholic |
IP |
150mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used |
|
|
|
24 |
Ursodeoxycholic Acid Tablets IP 300mg |
Each film coated tablet contains |
|
|
(IP 2010 Page No. 12.04.2001) |
|
|
Ursoodeoxycholic |
IP |
300mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used |
|
|
|
25 |
AlbendazoleTablets IP 400 mg |
Each uncoated tablet contains:- |
|
|
(IP 2010 Page No. 781) |
|
|
Albendazone |
IP |
400mg |
|
|
|
Excipients |
|
Q.S |
|
26 |
Terbinafine Tablets IP 250mg |
Each uncoated tablet contains |
|
|
(Sugam list dated:29/03/1995) |
|
|
Terbinafine Hydrochloride |
IP |
250mg |
|
|
|
Eq, to Terbinafine |
|
|
|
27 |
Rabeprazole &Domperidone Tablets. |
Each Enteric Coated Tablet Contains |
|
|
Kokate List Sr. No. 1606 Date of Approval 13.10.2016 |
|
|
Rabeprazole Sodium |
IP |
20mg |
|
|
|
Domperidone |
IP |
10mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used in coating. |
|
|
|
28 |
Pantoprazole & Domperidone Tablets |
Each Enteric coated tablet contains |
|
|
Kokate List Sr. No. 82 Date of Approval 17.07.15 |
|
|
Pantoprazole Sodium |
IP |
|
|
|
|
Eq. to Pantoprazole |
|
40mg |
|
|
|
Domperidone |
IP |
10mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour : Approved colour used in coating |
|
|
|
29 |
Serratiopeptidase with Diclofenac Sodium Tablets |
Each enteric coated tablet contains: |
|
|
(Sugam list dated. 24.01.2008) |
|
|
Diclofenac Sodium |
IP |
50mg |
|
|
|
Serratiopeptidase |
IP |
10mg |
|
|
|
(eq. to 20,000 Enzymatic Units) |
|
|
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used |
|
|
|
30 |
Ornidazole & Levofloxacin Tablets |
Each Film coated tablet contains |
|
|
Approved in Haryana |
|
|
Ornidazole |
IP |
500mg |
|
|
|
Levofloxacin Hemihydrate |
|
|
|
|
|
Equ. to Levofloxacin |
IP |
250mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: – Approved colour used in coating. |
|
|
|
31 |
Mefenamic Acid & Dicyclomine Hydrochloride Tablets IP |
Each uncoated tablet contains:- |
|
|
|
|
|
Mefenamic Acid |
IP |
250mg |
|
|
|
Dicyclomine Hydrochloride |
IP |
80mg |
|
32 |
Amlodipine & Metoprolol Succinate Tablets |
Each film coated tablet contains: |
|
|
(Sugam list dated: 07.02.2006) |
|
|
Amlodipine Besylate |
IP |
|
|
|
|
Eq. to Amlodipine |
|
5 mg |
|
|
|
Metoprolol Succinate |
IP |
|
|
|
|
Eq. to Metoprolol Tartrate |
|
50 mg |
|
|
|
(As Extended Release ) |
|
|
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used |
|
|
|
33 |
Gabapentin & Nortriptyline Hydrochloride Tablets |
Each Film coated tablet contains: |
|
|
Approved in Haryana |
|
|
Gabapentin |
IP |
400mg |
|
|
|
Nortriptyline Hydrochloride |
IP |
|
|
|
|
Eq. to Nortriptyline |
|
10 mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour- Approved colour used |
|
|
|
34 |
Lornoxicam & Paracetamol Tablets |
Each film coated tablet contains: |
|
|
Kokate List Sr. No. 122 Date of Approval 17.07.2015 |
|
|
Lornoxicam |
|
8mg |
|
|
|
Paracetamol |
IP |
325mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour- Approved colour used |
|
|
|
35 |
Etodolac 60mg & Thiocolchicoside 4mg Tablets |
Each film coated tablet contains |
|
|
( Sugam List Date: 09.09.10) |
|
|
Etodolac |
IP |
60mg |
|
|
|
Thocolchicoside |
IP |
4mg |
|
|
|
Colour: Approved colour used |
|
|
|
36 |
Etodolac 400mg & Thiocolchicoside 4mg Tablets |
Each film coated tablet contains |
|
|
( Sugam List Date: 09.09.10) |
|
|
Etodolac |
IP |
400mg |
|
|
|
Thocolchicoside |
IP |
4mg |
|
|
|
Colour: Approved colour used |
|
|
|
37 |
Glucosamine, Diacerein & Methylsulfonylmethane Tablets |
Each film coated tablet contains: |
|
|
Kokate List Sr. No. 1482 Date of Approval 13.10.2016 |
|
|
Glucosamine Sulphate Potassium Chloride |
USP |
750mg |
|
|
|
Diacerein |
IP |
50mg |
|
|
|
Methylsulfonylmethane |
USP |
250mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour : Approved colour used |
|
|
|
38 |
Tranexamic Acid & Mefenamic Acid Tablets |
Each film coated tablet contains: |
|
|
Kokate List Sr. No. 1448 Date of Approval 13.10.2016 |
|
|
Tranexamic Acid |
IP |
500mg |
|
|
|
Mefenamic Acid |
IP |
250mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour : Approved colour used |
|
|
|
39 |
Montelukast & Levocetrizine Dihydrochloride Tablets IP |
Each Film coated tablet contains: |
|
|
Kokate List Sr. No. 1159 Date of Approval 03.02.2016 |
|
|
Montelukast Sodium |
IP |
|
|
|
|
Eq. to Montelukast |
|
10 mg |
|
|
|
Levocetrizine Dihydrochloride |
IP |
5mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used |
|
|
|
40 |
Aceclofenac,Paracetamol & Thiocolchicoside Tablets |
Each Film coated tablet contains: |
|
|
Approved in Haryana |
|
|
Aceclofenac |
IP |
100mg |
|
|
|
Paracetamol |
IP |
325mg |
|
|
|
Thiocolchicoside |
IP |
4mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour- Approved colour used |
|
|
|
41 |
Citicoline & Piracetam Tablets |
Each film coated tablet contains: |
|
|
Kokate List Sr. No. 777 Date of Approval 17.07.2015 |
|
|
Citicoline sodium |
|
|
|
|
|
Eq. to Citicoline |
IP |
500 mg |
|
|
|
Piracetam |
IP |
800mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used |
|
|
|
42 |
Montelukast Sodium & Fexofenadine Hydrochloride Tablets |
Each film coated tablet contains |
|
|
(Sugam list dated: 31.08.10) |
|
|
Montelukast Sodium |
IP |
|
|
|
|
Eq. To Montelukast |
|
10mg |
|
|
|
Fexofenadine Hydrochloride |
IP |
120mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used |
|
|
|
43 |
Metformin Hydrochloride SR,Glimepiride &Voglibose Tablets |
Each uncoated bilayered tablet contains: |
|
|
Approved in Haryana |
|
|
Metformin Hydrochloride |
IP |
500mg |
|
|
|
(As sustained release form ) |
|
|
|
|
|
Glimepiride |
IP |
1mg |
|
|
|
Voglibose |
IP |
0.2mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour- Approved colour used |
|
|
|
44 |
Metformin Hydrochloride SR,Glimepiride &Voglibose Tablets |
Each uncoated bilayered tablet contains: |
|
|
|
|
|
Metformin Hydrochloride |
IP |
500mg |
|
|
|
(As sustained release form ) |
|
|
|
|
|
Glimepiride |
IP |
1mg |
|
|
|
Voglibose |
IP |
0.3mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour- Approved colour used |
|
|
|
45 |
Diclofenac Potassium & Paracetamol Tablets |
Each Uncoated Tablet Contains : |
|
|
|
|
|
Diclofenac Potassium |
BP |
50mg |
|
|
|
Paracetamol |
IP |
325mg |
|
46 |
“Levocetirizine Dihydrochloride, Montelukast Sodium & Ambroxol Hydrochloride (SR) Tablets |
“ |
Each uncoated bilayered tablet contains: |
|
|
|
|
|
Levocetirizine Dihydrochloride |
IP |
5mg |
|
|
|
Montelukast Sodium |
IP |
|
|
|
|
Eq. to Anhydrous Montelukast |
|
10 mg |
|
|
|
Ambroxol Hydrochloride |
IP |
75mg |
|
|
|
(As sustained release ) |
|
|
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour- Approved colour used |
|
|
|
47 |
“Glimepiride 1mg & Metformin Hydrochloride 500mg & Pioglitazone Hydrochloride 15 mg Tablets |
“ |
Each uncoated tablet contains |
|
|
(Sugam list dated:12/08/2005) |
|
|
Glimepiride |
IP |
1mg |
|
|
|
Metformin Hydrochloride |
IP |
500mg |
|
|
|
(As Extended Release Form) |
|
|
|
|
|
Pioglitazone Hydrochloride |
IP |
|
|
|
|
Eq. to Poioglitazone |
|
15mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used |
|
|
|
48 |
“Metformin Hydrochloride SR,Gliclazide SR &Pioglitazone Tablets |
“ |
Each uncoated bilayered tablet contains: |
|
|
(Sugam list dated: 28.05.2010) |
|
|
Metformin Hydrochloride |
IP |
500mg |
|
|
|
(As sustained release form ) |
|
|
|
|
|
Gliclazide |
IP |
30mg |
|
|
|
(As sustained release form ) |
|
|
|
|
|
Pioglitazone Hydrochloride |
IP |
|
|
|
|
Eq. to Pioglitazone |
|
15 mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour- Approved colour used |
|
|
|
49 |
Glimepiride 2mg & Metformin Hydrochloride 500 mg Tablets IP |
Each uncoated tablet contains |
|
|
(Sugam list dated: 13-11-2002) |
|
|
Glimepiride |
IP |
2mg |
|
|
|
Metformin Hydrochloride |
IP |
500mg |
|
|
|
(As Prolonged Release) |
|
|
|
|
|
Excipients |
Q.S |
|
|
|
|
Colour: Approved colour used |
|
|
|
50 |
Glimepiride 1mg & Metformin Hydrochloride 500 mg Tablets IP |
Each uncoated tablet contains |
|
|
(Sugam list dated:13-11-2002) |
|
|
Glimepiride |
IP |
1mg |
|
|
|
Metformin Hydrochloride |
IP |
500mg |
|
|
|
(As Prolonged Release) |
|
|
|
|
|
Excipients |
Q.S |
|
|
|
|
Colour: Approved colour used |
|
|
|
51 |
Amlodipine & Atenolol Tablets IP |
Each uncoated tablet contains: |
|
|
(Sugam list dated:20.05.1996) |
|
|
Amlodipine Besylate |
IP |
|
|
|
|
Eq. to Amlodipine |
|
5 mg |
|
|
|
Atenolol |
IP |
50 mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used |
|
|
|
52 |
Albendazole & Ivermectin Tablets |
Each uncoated tablet contains |
|
|
(Sugam list Dated: 25.04.09) |
|
|
Albendazone |
IP |
400mg |
|
|
|
Ivermectin |
IP |
6mg |
|
53 |
Etoricoxib & Paracetamol Tablet |
Each uncoated tablet contains |
|
|
|
|
|
Etoricoxib |
IP |
60mg |
|
|
|
Paracetamol |
IP |
325mg |
|
|
|
Excipients |
|
Q.S |
|
54 |
Cetirizine Hydrochloride 5mg, Phenylephrine Hydrochloride 5mg & Paracetamol 500mg Tablets |
Each Uncoated Tablet Contains |
|
|
Approved in Haryana |
|
|
Cetirizine Hydrochloride |
IP |
5mg |
|
|
|
Phenylephrine Hydrochloride |
IP |
5mg |
|
|
|
Paracetamol |
IP |
500mg |
|
|
|
Excipients |
|
Q.S |
|
|
|
Colour: Approved colour used |
|
|
|